News

Applications are open for AHS 2026 Emerging Leaders, a program dedicated to cultivating the next generation of leaders in headache medicine.

AHS is excited to introduce the 2026-2028 Board of Directors. These elected leaders will guide the Society's mission to advance headache medicine through research, education, clinical care, and service to the headache community.

On June 24, 2026, over 30,000 purple flags stood strong near the Washington Monument, together symbolizing the 40 million Americans living with migraine and headache disorders, as advocates, clinicians, and patients gathered for Speak Out for Headache Health at the Flags for Headache installation in Washington, DC. 

Over a thousand headache medicine professionals from around the world met in Orlando for the 68th Annual Scientific Meeting in June.

Register for the 2026 Scottsdale Headache Symposium for sessions, workshops, and networking opportunities focused on advancing headache medicine.

Applications are open for the 2026 AHS Resident Education Program. Apply by August 9 for an immersive weekend in headache medicine.

The APP SIG is strengthening connection and education to support advanced practice providers across AHS.

Get a first look at the 68th Annual Scientific Meeting, where leaders in headache medicine come together for science, collaboration, and discovery.

Meet the 2026 Annual Scientific Meeting award recipients, recognized for excellence in research, service, and clinical care.

More than 280 advocates came together in Washington, D.C., for Headache on the Hill 2026 to advance care, research, and policy. See how this growing movement is turning advocacy into action on Capitol Hill and beyond.

The AHS Practice Management Committee helps members manage the operational and regulatory side of headache medicine. Through education, resources, and advocacy, it provides guidance on coding, billing, reimbursement, and practice operations while supporting sustainable, high-quality care.

The 2026 International Headache Academy brought together 54 early-career clinicians and researchers for an immersive program advancing headache medicine. Through hands-on sessions, research presentations, and expert discussions, attendees explored new ways to innovate, collaborate, and put patient needs first.

The American Headache Society, in collaboration with Pfizer, announces the Migraine & Women’s Health Grant through the Headache & Migraine Competitive Grant Program. Funding of up to $200,000 over two years is available for collaborative projects addressing migraine’s disproportionate impact on women.

First Contact provides headache education to physicians working in primary care, urgent care, and emergency settings to improve care for patients with headache.